FIELD: pharmacy.
SUBSTANCE: invention relates to new derivatives of formula (I) Q: (A) or (B) phenylpyrrole, or pharmaceutically acceptable salts thereof, which are useful for prevention or treatment of diseases such as dementia, Alzheimer's disease, attention deficit, hyperactivity disorder, schizophrenia, epilepsy, "central" cramp, obesity, diabetes, hyperlipidemia, narcolepsy, idiopathic hypersomnia, behavior-induced insufficient sleep syndrome, sleep apnea syndrome, circadian rhythm, parasomnia, sleep-related traffic violation, insomnia and depression, or allergic rhinitis.
EFFECT: increased compound application effeciency.
13 cl, 3 tbl, 10 ex
Title | Year | Author | Number |
---|---|---|---|
SUBSTITUTED N-PHENYLBIPYRROLIDINE CARBOXAMIDES AND THERAPEUTIC USE THEREOF | 2008 |
|
RU2477719C2 |
CONDENSED 4-OXOPYRIMIDINE DERIVATIVE | 2005 |
|
RU2358969C2 |
SUBSTITUTED N-PHENYLPYRROLIDINYL METHYLPYRROLIDINE AMIDES AND THERAPEUTIC USE THEREOF AS MODULATORS OF HISTAMINE H3 RECEPTOR | 2008 |
|
RU2477721C2 |
PHENYLPYRAZOL DERIVATIVES | 2008 |
|
RU2480456C2 |
OCTAHYDROPYRROLO[3,4-b]PYRROLE DERIVATIVES (VERSIONS), METHOD OF OBTAINING OCTAHYDROPYRROLO[3,4-b]PYRROLE DERIVATIVES (VERSIONS), BASED ON THEM PHARMACEUTICAL COMPOSITION AND METHOD OF TREATING DISEASE OR IMPAIRMENT OF STATE OF ORGANISM, SENSITIVE TO MODULATION OF HISTAMINE-3 RECEPTOR ACTIVITY | 2007 |
|
RU2492172C2 |
AZA-SUBSTITUTED SPIRO-DERIVATIVES | 2006 |
|
RU2428423C2 |
DERIVATIVES OF 1,1-DIOXOTHIOMORPHOLINYLINDOLYL METHANONE FOR USE AS HISTAMINASE MODULATORS | 2006 |
|
RU2412182C2 |
OCTAHYDRO-PYRROLO[3,4-b]PYRROL N-OXIDES | 2008 |
|
RU2486187C2 |
AZAINDOLE-2-CARBOXAMIDE DERIVATIVES | 2006 |
|
RU2417226C2 |
BENZIMIDAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF | 2008 |
|
RU2451017C2 |
Authors
Dates
2017-05-03—Published
2012-12-07—Filed